AstraZeneca Pharma India Ltd. — Regulatory Filings 2024

Feb 8, 2024

AstraZeneca4

February 8, 2024

==> picture [102 x 95] intentionally omitted <==

----- Start of picture text -----

4
.,,,m
a
----- End of picture text -----

The Manager - Listing BSE Limited l[st ] Floor, New Trading Ring Rotunda Building, P J Towers, Dalal Street, Fort, Mumbai - 400001

The Manager - Listing National Stock Exchange of India Ltd. Exchange Plaza, 5[th ] Floor, Plot No. C/1, G Block Bandra-Kurla Complex, Bandra (E), Mumbai - 400051

Dear Sir(s)

Sub: Outcome of the Board Meeting held on Thursday, Februar 8, 2024

Ref: Scrip Code - BSE: 506820 / NSE: ASTRAZEN

At the Board Meeting of the Company held on Thursday, February 8, 2024, the Board of Directors considered and approved the Unaudited Financial Results of the Company for the quarter ended December 31, 2023. The said Unaudited Financial Results together with the Limited Review Report of the Statutory Auditors dated December 31, 2023 are enclosed herewith.

The Meeting commenced at 2:45 P.M. and concluded at 5:55 P.M. (1ST).

Kindly take the above on your records.

Thanking you Yours faithfully

For AstraZeneca Pharma India Limited

==> picture [74 x 34] intentionally omitted <==

Manasa. R Company Secreta Encl: As above

TEL : +91 80 6774 8000 FACTORY TEL : +91 80 6774 9000 12th Mile on Bellary Road FAX : +91 80 6774 8857 Venkatala, Kattigenahalli Village CIN : L24231KA1979PLC003563 Yelahanka FAX : +91 80 2846 2208 Bangalore - 560 063 +91 80 6774 9628 WEB : www.astrazeneca.com/india INDIA

CORPORATE & REGO. OFFICE AstraZeneca Pharma India Ltd. P. B. No . 4525, Block N1, 12th Floor, Manyata Embassy Business Park, Rachenahalli, Outer Ring Road, Bangalore - 560 045, INDIA